Immunogenetics: Untangling the immune basis of disease susceptibility

Interactions between immune cell receptors and proteins that determine disease susceptibility shed light on how different arms of the immune system are involved in three viral infections and Crohn's disease.
  1. Ruy M Ribeiro  Is a corresponding author
  2. Luis Graca
  1. Laboratório de Biomatemática, Instituto de Saúde Ambiental, Faculdade de Medicina, Universidade de Lisboa, Portugal
  2. Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Portugal

Why do people respond differently to the same infectious agent? A possible answer is that differences in the immune responses of individuals, caused by genetic variability between them, are responsible. Indeed, many studies have looked for associations between genes involved in immunity and disease outcome (Buniello et al., 2019), and it has been found that a gene complex called the human leukocyte antigen (HLA) system has a central role (Matzaraki et al., 2017).

The HLA genes encode the major histocompatibility complex (MHC). MHC proteins are found on the surface of cells and each one presents peptides from proteins within the cell (either proteins native to the cell or from foreign entities like bacteria) to immune cells. Thus, MHC proteins allow immune cells to recognize if a given cell is dangerous or not. For example, immune cells called CD8+ T lymphocytes recognize cells that have been infected with viruses because receptors on these T cells bind specific MHC proteins loaded with viral peptides on the surface of the infected cells. Likewise, other types of immune cells – such as natural killer cells, macrophages and dendritic cells – have receptors that bind to other parts of the MHC protein displayed by infected cells (Augusto and Petzl-Erler, 2015; Hudson and Allen, 2016).

The HLA is extremely diverse among individuals. It has been assumed that the association between some diseases and certain HLA alleles is evidence for a central role of CD8+ T cells in that disease. However, given that the HLA can also interact with receptors on other immune cells, disentangling the contributions of the different arms of the immune system remains a challenge. Now, in eLife, Becca Asquith of Imperial College and colleagues – including Bisrat Debebe as first author, researchers from various institutes in the UK and US, and the IAVI Protocol C Investigators – report the results of a new approach to disentangling these contributions (Debebe et al., 2020).

Debebe et al. reasoned that it may be possible to predict which immune cells are responsible for fighting a specific disease since receptors from particular immune cells interact with different regions of the MHC protein. For example, susceptibility to a disease may be associated with individuals carrying MHC proteins that are similar in the region that presents protein fragments to the T-cell receptor (which can be thought of as being similar in ‘T-cell receptor space’). If this is the case, then CD8+ T cells are likely involved in fighting the disease. The same reasoning can be made for associations with the other receptors, such as the killer immunoglobulin-like receptor (KIR) receptors in natural killer cells and leukocyte immunoglobulin-like receptor (LILR) in myeloid cells (Figure 1).

Axes of similarity in MHC proteins.

Debebe et al. showed that similarities in regions of the MHC molecule that interact with different immune cell receptors can be thought of in terms of different 'spaces' (which are defined by an axis for each type of receptor). They found that MHCs that are similar in the T-cell receptor (TCR) axis are associated with disease outcomes for HLTV-1, hepatitis C virus (HCV) and HIV-1. Disease outcomes for HIV-1 are also associated with MHCs that show similarity in the killer immunoglobulin-like receptor (KIR) axis. For the diseases tested, no MHCs were found to be similar in the region that interacts with the leukocyte immunoglobulin-like receptor (LILR) carried by myeloid cells (MC). CD8: CD8+ T cells; NK: natural killer cells; blue circle: peptide.

The challenge in this method is defining MHC similarity. Debebe et al. did so by taking an HLA known to associate with a specific disease outcome and predicting its ability to bind to different immune cell receptors. Next, they compared this predicted binding ability to that of all other HLAs, and found the HLAs with the highest binding similarity. Finally, they checked if these HLAs are also associated with disease susceptibility.

Debebe et al. applied this method to three infections (human T-cell leukemia virus type one or HTLV-1; hepatitis C virus; and HIV-1) and one autoimmune disease (Crohn’s disease). They used well-characterized cohorts where both the HLA and the outcome of the disease were known for each individual.

They studied three known HLA-outcome associations for HTLV-1 and found that other HLAs that were similar in T-cell receptor space were also associated with HTLV-1. However, other HLAs that were similar to these three HLAs in LILR space or KIR space (see Figure 1) were not associated with HTLV-1. Thus, they concluded that HTLV-1 is most likely controlled by CD8+ T cells. They also studied three HLA-outcome associations for hepatitis C, reaching the same conclusion: disease outcome is mostly controlled by CD8+ T cells. For HIV-1, Debebe et al. found that natural killer cells and CD8+ T cells both have a role, which is consistent with previous results (Bashirova et al., 2011; McBrien et al., 2018). They also studied two known HLA-outcome associations for Crohn’s disease in a large sample (2650 individuals), but other HLAs that were similar in T-cell, LILR or KIR space did not have significant effect on Crohn's disease outcome.

The approach suggested by Debebe et al. generates insights into which immune cells may be involved in fighting a disease. There are two issues that need to be explored further. First, while we know a great deal about T-cell receptors, we know less about KIR, and even less about LILR binding (Hirayasu and Arase, 2015). This knowledge (or lack thereof) is part of the definition of similarity used by Debebe et al., which can and should be updated as more data becomes available (Gwozdowicz et al., 2019). The second issue pertains to the fact that it may be possible to define similarity in other ways, leading to different results that provide further insights into how genetic variability affects the immune response.


Article and author information

Author details

  1. Ruy M Ribeiro

    Ruy M Ribeiro is at the Laboratório de Biomatemática, Instituto de Saúde Ambiental, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal

    For correspondence
    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3988-8241
  2. Luis Graca

    Luis Graca is in the Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisboa, Portugal

    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6935-8500

Publication history

  1. Version of Record published: May 14, 2020 (version 1)


© 2020, Ribeiro and Graca

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.


  • 2,385
    Page views
  • 256
  • 0

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Ruy M Ribeiro
  2. Luis Graca
Immunogenetics: Untangling the immune basis of disease susceptibility
eLife 9:e56886.
  1. Further reading

Further reading

    1. Computational and Systems Biology
    2. Evolutionary Biology
    Serkan Sayin, Brittany Rosener ... Amir Mitchell
    Research Advance

    Drug metabolism by the microbiome can influence anti-cancer treatment success. We previously suggested that chemotherapies with antimicrobial activity can select for adaptations in bacterial drug metabolism that can inadvertently influence the host's chemoresistance. We demonstrated that evolved resistance against fluoropyrimidine chemotherapy lowered its efficacy in worms feeding on drug-evolved bacteria (Rosener et al., 2020). Here we examine a model system that captures local interactions that can occur in the tumor microenvironment. Gammaproteobacteria colonizing pancreatic tumors can degrade the nucleoside-analog chemotherapy gemcitabine and, in doing so, can increase the tumor's chemoresistance. Using a genetic screen in Escherichia coli, we mapped all loss-of-function mutations conferring gemcitabine resistance. Surprisingly, we infer that one third of top resistance mutations increase or decrease bacterial drug breakdown and therefore can either lower or raise the gemcitabine load in the local environment. Experiments in three E. coli strains revealed that evolved adaptation converged to inactivation of the nucleoside permease NupC, an adaptation that increased the drug burden on co-cultured cancer cells. The two studies provide complementary insights on the potential impact of microbiome adaptation to chemotherapy by showing that bacteria-drug interactions can have local and systemic influence on drug activity.

    1. Computational and Systems Biology
    2. Neuroscience
    Andrew McKinney, Ming Hu ... Xiaolong Jiang
    Research Article

    The locus coeruleus (LC) houses the vast majority of noradrenergic neurons in the brain and regulates many fundamental functions including fight and flight response, attention control, and sleep/wake cycles. While efferent projections of the LC have been extensively investigated, little is known about its local circuit organization. Here, we performed large-scale multi-patch recordings of noradrenergic neurons in adult mouse LC to profile their morpho-electric properties while simultaneously examining their interactions. LC noradrenergic neurons are diverse and could be classified into two major morpho-electric types. While fast excitatory synaptic transmission among LC noradrenergic neurons was not observed in our preparation, these mature LC neurons connected via gap junction at a rate similar to their early developmental stage and comparable to other brain regions. Most electrical connections form between dendrites and are restricted to narrowly spaced pairs or small clusters of neurons of the same type. In addition, more than two electrically coupled cell pairs were often identified across a cohort of neurons from individual multi-cell recording sets that followed a chain-like organizational pattern. The assembly of LC noradrenergic neurons thus follows a spatial and cell type-specific wiring principle that may be imposed by a unique chain-like rule.